Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 42,69
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 61,64
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Librería: preigu, Osnabrück, Alemania
EUR 38,70
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Enhancing Irbesartan Bioavailability via Solid Dispersion | Optimizing Dissolution of Irbesartan Through Advanced Solid Dispersion Techniques | Rashmitha Vallala (u. a.) | Taschenbuch | Englisch | 2024 | LAP LAMBERT Academic Publishing | EAN 9786208119713 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 44,74
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Librería: Majestic Books, Hounslow, Reino Unido
EUR 59,58
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Sep 2024, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 43,90
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 84 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 61,06
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Sep 2024, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 43,90
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 ¿g/ml) limits its bioavailability. This study aimed to improve Irbesartan's solubility through solid dispersions using carriers like ß-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. ß-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug's transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that ß-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using ß-cyclodextrin in solid dispersions effectively enhances Irbesartan's solubility and therapeutic potential in treating hypertension.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 84 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2024
ISBN 10: 6208119715 ISBN 13: 9786208119713
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 44,59
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Hypertension is a prevalent condition, especially in those over 50, and can lead to severe cardiovascular complications. Irbesartan, an angiotensin II receptor blocker (ARB), is commonly used to manage hypertension, but its low aqueous solubility (1 ¿g/ml) limits its bioavailability. This study aimed to improve Irbesartan¿s solubility through solid dispersions using carriers like ¿-cyclodextrin, HPMC K4M, PEG4000, and Gelatin. ¿-cyclodextrin showed the greatest enhancement in solubility, as confirmed by phase solubility studies. Characterization through DSC and SEM indicated the drug¿s transformation from crystalline to amorphous form, improving dissolution. FTIR studies confirmed no interaction between the drug and carriers. In vitro dissolution tests revealed that ¿-cyclodextrin (1:9) formulations significantly increased the dissolution rate compared to pure Irbesartan and other carriers. Thus, using ¿-cyclodextrin in solid dispersions effectively enhances Irbesartan¿s solubility and therapeutic potential in treating hypertension.